Safety of dupilumab in a 5-month-old infant with severe atopic dermatitis.

Havele, Sonia A; Khurana, Michele C; McMahon, Patrick; Murthy, Aditi S; Perman, Marissa J; Treat, James R

Havele, Sonia A; Khurana, Michele C; McMahon, Patrick; Murthy, Aditi S; Perman, Marissa J; Treat, James R.

Afiliación

Havele SA; Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Khurana MC; Section of Dermatology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
McMahon P; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Murthy AS; Section of Dermatology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Perman MJ; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Treat JR; Section of Dermatology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Pediatr Dermatol ; 39(2): 291-294, 2022 Mar.

Article en En | MEDLINE | ID: mdl-35434859

Asunto(s)

Anticuerpos Monoclonales Humanizados; Dermatitis Atópica; Anticuerpos Monoclonales Humanizados/efectos adversos; Anticuerpos Monoclonales Humanizados/uso terapéutico; Dermatitis Atópica/tratamiento farmacológico; Humanos; Lactante; Interleucina-4; Masculino; Índice de Severidad de la Enfermedad; Resultado del Tratamiento

Palabras clave

atopic dermatitis; dupilumab; eczema; monoclonal antibody; systemic therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dermatitis Atópica / Anticuerpos Monoclonales Humanizados Límite: Humans / Infant / Male Idioma: En Revista: Pediatr Dermatol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google